[
1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide. IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer; 2013.
]Search in Google Scholar
[
2. Creasman WT, Eddy GL. Recent advances in endometrial cancer. Semin Surg Oncol. 1990, 6, 339-342.
]Search in Google Scholar
[
3. Saso S, Chatterjee J, Georgiou E, et al. S. Endometrial cancer. BMJ 2011, 343, d3954.
]Search in Google Scholar
[
4. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15:10-17.
]Search in Google Scholar
[
5. Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet 2005, 366, 491-505.
]Search in Google Scholar
[
6. Soslow RA, Tornos C, Park KJ, et al. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists. Int. J Gynecol Pathol. 2019, 38 (Suppl. 1), 64-74.
]Search in Google Scholar
[
7. Group S.G.O.C.P.E.C.W, Burke WM, Orr J, et al. Endometrial cancer: A review and current management strategies: Part II. Gynecol. Oncol. 2014, 134, 393-402.
]Search in Google Scholar
[
8. Moore KN, Fader AN. Uterine papillary serous carcinoma. Clin Obstet Gynecol. 2011, 54, 278-291.
]Search in Google Scholar
[
9. Hamilton CA, Cheung MK, Osann K, et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer 2006, 94, 642-646.
]Search in Google Scholar
[
10. Ismail E. Invasion of lymphatic and blood vessels in endometrial endometroid carcinoma – FIGO stage I. Medical University, Varna. 2019.
]Search in Google Scholar
[
11. Querleu D, Cibula D, Abu-Rustum NR. 2017 Update on the Querleu-Morrow Classification of Radical Hysterectomy. Ann Surg Oncol. 2017;24(11):3406-3412.
]Search in Google Scholar
[
12. Amant F, Mirza MR, Koskas M, Creutzberg CL. (2018), Cancer of the corpus uteri. Int J Gynecol Obstet, 143: 37-50.
]Search in Google Scholar
[
13. American College of Obstetricians and Gynecologists ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: Management of endometrial cancer. Obstet Gynecol. 2005;106:413-425.
]Search in Google Scholar
[
14. Goff B, Kato D, Schmidt RA et al. Uterine Papillary Serous Carcinoma: Patterns of Metastatic Spread. Gynecologic oncology; 1994; 54 (3): 264-268.
]Search in Google Scholar
[
15. Panici PB, Basile S, Maneschi F et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: Randomized clinical trial. J Natl Cancer Inst. 2008;100:1707-1716.
]Search in Google Scholar
[
16. Kitchener H, Swart AM, Qian 4, et al. ASTEC study group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study. Lancet. 2009;373:125-136. Published erratum appears in Lancet 2009; 373: 1764.
]Search in Google Scholar
[
17. Todo Y, Kato H, Kaneuchi M et al. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): A retrospective cohort analysis. Lancet. 2010;375:1165–1172.
]Search in Google Scholar
[
18. Casarin J, Bogani G, Piovano E, et al. Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma. J Gynecol Oncol. 2020;31:e64.
]Search in Google Scholar
[
19. Mahdi H, Kumar S, Al-Wahab Z, et al. Prognostic impact of lymphadenectomy in uterine serous cancer. BJOG. 2013 Mar;120(4):384-391.
]Search in Google Scholar
